Long Corridor Asset Management LTD Syndax Pharmaceuticals Inc Transaction History
Long Corridor Asset Management LTD
- $115 Million
- Q4 2024
A detailed history of Long Corridor Asset Management LTD transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Long Corridor Asset Management LTD holds 10,000 shares of SNDX stock, worth $156,400. This represents 0.11% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$156,400
Previous $192,000
31.25%
% of portfolio
0.11%
Previous 0.22%
Shares
1 transactions
Others Institutions Holding SNDX
# of Institutions
233Shares Held
96.9MCall Options Held
1.39MPut Options Held
543K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$133 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$124 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$93.1 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.31MShares$83.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$76.4 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $885M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...